FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137417692> ?p ?o ?g. }

• W2137417692 abstract "A residual risk of cardiovascular disease tends to persist despite standard prevention therapy with statins. This may stem partly from increased oxidized low-density lipoprotein (LDL) levels. However, how oxidized LDL can be further reduced beyond statin therapy in high-risk diabetes patients remains unclear. We aimed to clarify the clinical factors associated with oxidized LDL levels in statin-treated high-risk diabetes patients. This cross-sectional observational study included 210 diabetes patients with coronary artery diseases (CAD) who were treated with statins. We determined serum malondialdehyde-modified LDL (MDA-LDL), LDL cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride (TG), remnant lipoprotein cholesterol, hemoglobin (Hb) A1c, adiponectin, and C-reactive protein (CRP) levels and investigated the factors influencing the MDA-LDL level. In univariate analysis, the MDA-LDL level was significantly correlated with LDL cholesterol (p < 0.0001), TG (p < 0.0001), HDL cholesterol (p = 0.017), and adiponectin (p = 0.001) levels but not with age, body mass index, waist circumference, blood pressure, or HbA1c levels. Even after adjusting for the LDL cholesterol level, the correlations between the MDA-LDL level and the TG, HDL cholesterol, and adiponectin levels were still significant. Among these significant factors, multivariate analysis revealed that the MDA-LDL level was independently associated with the LDL cholesterol, TG, and HDL cholesterol but not with adiponectin levels. The MDA-LDL level was also significantly associated with the CRP level (p = 0.014) and the remnant lipoprotein cholesterol level (p < 0.0001) independently of the LDL cholesterol level. The number of metabolic syndrome (MS) components was significantly associated with the MDA-LDL/LDL cholesterol ratio (p < 0.0001). Furthermore, the use of metformin and α-glucosidase inhibitors was inversely associated with high MDA-LDL levels (p = 0.033 and 0.018, respectively). In statin-treated diabetes patients with CAD, the MDA-LDL level was significantly correlated with TG and HDL cholesterol levels. Adiponectin level was also significantly associated with the MDA-LDL level, but not independent of the above-mentioned factors. The management of dyslipidemic MS components, including the use of metformin or α-glucosidase inhibitors, may be important for reducing the oxidized LDL levels beyond statin therapy in high-risk diabetes patients." @default.
• W2137417692 created "2016-06-24" @default.
• W2137417692 creator A5022630091 @default.
• W2137417692 creator A5034976943 @default.
• W2137417692 creator A5039706005 @default.
• W2137417692 creator A5044923497 @default.
• W2137417692 creator A5053272189 @default.
• W2137417692 creator A5058456419 @default.
• W2137417692 creator A5068763661 @default.
• W2137417692 creator A5084885924 @default.
• W2137417692 date "2013-12-01" @default.
• W2137417692 modified "2023-10-09" @default.
• W2137417692 title "Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease" @default.
• W2137417692 cites W1965296835 @default.
• W2137417692 cites W1966751645 @default.
• W2137417692 cites W1975060018 @default.
• W2137417692 cites W1981261500 @default.
• W2137417692 cites W1986349550 @default.
• W2137417692 cites W1990955172 @default.
• W2137417692 cites W1995365380 @default.
• W2137417692 cites W2001047636 @default.
• W2137417692 cites W2026825032 @default.
• W2137417692 cites W2028399029 @default.
• W2137417692 cites W2035547373 @default.
• W2137417692 cites W2041963174 @default.
• W2137417692 cites W2049965571 @default.
• W2137417692 cites W2058566397 @default.
• W2137417692 cites W2060501593 @default.
• W2137417692 cites W2062778001 @default.
• W2137417692 cites W2077119741 @default.
• W2137417692 cites W2080904659 @default.
• W2137417692 cites W2083342497 @default.
• W2137417692 cites W2095238078 @default.
• W2137417692 cites W2096478205 @default.
• W2137417692 cites W2101383059 @default.
• W2137417692 cites W2104041304 @default.
• W2137417692 cites W2117187480 @default.
• W2137417692 cites W2118154631 @default.
• W2137417692 cites W2118723490 @default.
• W2137417692 cites W2119475547 @default.
• W2137417692 cites W2122115743 @default.
• W2137417692 cites W2124821727 @default.
• W2137417692 cites W2126999212 @default.
• W2137417692 cites W2127934772 @default.
• W2137417692 cites W2131385716 @default.
• W2137417692 cites W2131398405 @default.
• W2137417692 cites W2131541226 @default.
• W2137417692 cites W2135659886 @default.
• W2137417692 cites W2136976666 @default.
• W2137417692 cites W2138226825 @default.
• W2137417692 cites W2146345840 @default.
• W2137417692 cites W2150545098 @default.
• W2137417692 cites W2153647382 @default.
• W2137417692 cites W2159918504 @default.
• W2137417692 cites W2160256386 @default.
• W2137417692 cites W2160414137 @default.
• W2137417692 cites W2167067204 @default.
• W2137417692 cites W2172502596 @default.
• W2137417692 cites W2188846692 @default.
• W2137417692 cites W2247997571 @default.
• W2137417692 cites W2326202471 @default.
• W2137417692 cites W4230123249 @default.
• W2137417692 cites W4254970980 @default.
• W2137417692 doi "https://doi.org/10.1186/1758-5996-5-77" @default.
• W2137417692 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4029151" @default.
• W2137417692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24314067" @default.
• W2137417692 hasPublicationYear "2013" @default.
• W2137417692 type Work @default.
• W2137417692 sameAs 2137417692 @default.
• W2137417692 citedByCount "13" @default.
• W2137417692 countsByYear W21374176922014 @default.
• W2137417692 countsByYear W21374176922015 @default.
• W2137417692 countsByYear W21374176922016 @default.
• W2137417692 countsByYear W21374176922017 @default.
• W2137417692 countsByYear W21374176922018 @default.
• W2137417692 countsByYear W21374176922019 @default.
• W2137417692 countsByYear W21374176922021 @default.
• W2137417692 crossrefType "journal-article" @default.
• W2137417692 hasAuthorship W2137417692A5022630091 @default.
• W2137417692 hasAuthorship W2137417692A5034976943 @default.
• W2137417692 hasAuthorship W2137417692A5039706005 @default.
• W2137417692 hasAuthorship W2137417692A5044923497 @default.
• W2137417692 hasAuthorship W2137417692A5053272189 @default.
• W2137417692 hasAuthorship W2137417692A5058456419 @default.
• W2137417692 hasAuthorship W2137417692A5068763661 @default.
• W2137417692 hasAuthorship W2137417692A5084885924 @default.
• W2137417692 hasBestOaLocation W21374176921 @default.
• W2137417692 hasConcept C126322002 @default.
• W2137417692 hasConcept C134018914 @default.
• W2137417692 hasConcept C2776782570 @default.
• W2137417692 hasConcept C2776839432 @default.
• W2137417692 hasConcept C2777391703 @default.
• W2137417692 hasConcept C2778096610 @default.
• W2137417692 hasConcept C2778163477 @default.
• W2137417692 hasConcept C2778913445 @default.
• W2137417692 hasConcept C2780072125 @default.
• W2137417692 hasConcept C2780578515 @default.
• W2137417692 hasConcept C555293320 @default.
• W2137417692 hasConcept C71924100 @default.
• W2137417692 hasConceptScore W2137417692C126322002 @default.

• next